| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/26/2009 | US20090054451 Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity |
| 02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 02/26/2009 | US20090054431 Novel heterocycle compounds |
| 02/26/2009 | US20090054425 Protein kinase inhibitors |
| 02/26/2009 | US20090054424 Optically active pyridine derivative and a medicament containing the same |
| 02/26/2009 | US20090054423 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | US20090054409 [4-(4-imidazo[1,2-a]pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-morpholin-4-yl-methanone, used for treating rheumatoid arthritis in mammals |
| 02/26/2009 | US20090054394 Polymorphisms in mgst3 are associated with elevated alat levels after ximelagatran treatment |
| 02/26/2009 | US20090054393 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 02/26/2009 | US20090054390 Use of haptoglobin genotyping in diagnosis and treatment of intraplaque hemorrhage resulting from plaque rupture |
| 02/26/2009 | US20090054381 Methods for treating respiratory disorders |
| 02/26/2009 | US20090054373 Chitin derivatives for hyperlipidemia |
| 02/26/2009 | US20090054371 Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof |
| 02/26/2009 | US20090054356 1-substituted-7-(b-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 02/26/2009 | US20090054347 Kinin b1 receptor peptide agonists and uses thereof |
| 02/26/2009 | US20090054340 Use of heat-shock protein 27 for cardiovascular disease prevention and treatment |
| 02/26/2009 | US20090054337 Natriuretic polypeptides |
| 02/26/2009 | US20090054336 Binding Agent |
| 02/26/2009 | US20090054328 Reagents and Methods for Modulating Gene Expression Related to Hypertension |
| 02/26/2009 | US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT |
| 02/26/2009 | US20090054308 administering to a patient A therapeutically effective amounts of an endothelin receptor antagonist e.g. ambrisentan, bosentan etc. and (S)-2-amino-3-(4-(2-amino-6-((R)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid to treat pulmonary hypertension |
| 02/26/2009 | US20090054302 Methods and Preparations For Curing Clinically Ill Patients |
| 02/26/2009 | US20090054248 Connexin 40 tissue specific gene mutations |
| 02/26/2009 | US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/26/2009 | US20090053334 Ghrelin production promoter |
| 02/26/2009 | US20090053277 Cell Sheet Containing Mesenchymal Stem Cells |
| 02/26/2009 | US20090053231 Optical Disc Apparatus |
| 02/26/2009 | US20090053224 Lox and loxl2 inhibitors and uses thereof |
| 02/26/2009 | US20090053208 Methods and Systems for Improving Tissue Perfusion |
| 02/26/2009 | US20090053199 Stable Dairy Components Effective for Fat Loss |
| 02/26/2009 | US20090053194 Method of treating or preventing biological or immunological responses to a reactive chemical or biological or toxic agent |
| 02/26/2009 | US20090053180 Tandem cardiac pacemaker system |
| 02/26/2009 | CA2697252A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 02/26/2009 | CA2696693A1 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 02/26/2009 | CA2695511A1 4-pyrimidinesulfamide derivative |
| 02/26/2009 | CA2694604A1 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators |
| 02/25/2009 | EP2028274A2 An antisense oligonucleotide against the TGF-beta2 gene |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2027872A1 Neurotoxic component of a botulinum toxin for treating a facial disease |
| 02/25/2009 | EP2027869A2 Neuregulin in the treatment of heart diseases |
| 02/25/2009 | EP2027864A1 Composition for improvement of lipid metabolism |
| 02/25/2009 | EP2027859A1 Anhydrous compositions for increasing blood flow |
| 02/25/2009 | EP2027858A1 Methods for attaining enhanced sexual wellness using anhydrous compositions |
| 02/25/2009 | EP2027857A2 Anhydrous compositions useful for attaining enhanced sexual wellness |
| 02/25/2009 | EP2027853A2 Kinase inhibitors for treating cancers |
| 02/25/2009 | EP2027851A1 Topical pharmaceutical formulations and methods of treatment |
| 02/25/2009 | EP2027783A1 Functional food composition that is rich in phenolic compounds and use of said composition |
| 02/25/2009 | EP2027118A2 Polymorphs of (r)-5-(2-aminoethyl)-1-(6,8-difluorochroman-3-yl)-1,3-dihydroimidazole-thione hydrochloride |
| 02/25/2009 | EP2027096A1 Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors |
| 02/25/2009 | EP2026833A2 Methods for inhibiting cardiac pai-1 |
| 02/25/2009 | EP2026817A1 Use of drospirenone for preventing high blood pressure in prehypertensive patients |
| 02/25/2009 | EP2026798A1 Pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel modulators |
| 02/25/2009 | EP2026796A2 Use of a vasopeptidase inhibitor for the treatment of pulmonary arterial hypertension |
| 02/25/2009 | EP2026769A1 Bilayer tablet for preventing cardiovascular events |
| 02/25/2009 | EP1904476B1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 02/25/2009 | EP1878732B1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR |
| 02/25/2009 | EP1642963B1 Lactobacillus casei lc2w strain and its use in antihypertensive aspect |
| 02/25/2009 | EP1572246B1 Novel compositions of magnetic particles covered with gem-bisphosphonate derivatives |
| 02/25/2009 | EP1365651A4 Composition and methods for modulation of vascular structure and/or function |
| 02/25/2009 | EP1317289B1 Dominant negative PLB mutant for use in treating cardiac disease |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | CN101375160A Potentiation of apoptosis by monoclonal antibodies |
| 02/25/2009 | CN101374844A Pyrrolopyridazinone compound |
| 02/25/2009 | CN101374841A Spiro imidazole derivatives as PPAR modulators |
| 02/25/2009 | CN101374571A Na/K-ATPase ligand |
| 02/25/2009 | CN101374553A Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients |
| 02/25/2009 | CN101374538A Pharmaceutical for promoting functional regeneration of damaged tissue |
| 02/25/2009 | CN101372508A Polypeptide and use thereof |
| 02/25/2009 | CN101371924A Therapy of autoimmune disease in a patient with an inadequate response to a TNF-ALPHA inhibitor |
| 02/25/2009 | CN101371923A BAFF receptor (BCMA), an immunoregulatory agent |
| 02/25/2009 | CN101371917A Brain protein hydrolysate sodium chloride injection and preparation method thereof |
| 02/25/2009 | CN101371913A Quality control method of medicament for treatingcardiovascular and cerebrovascular diseases |
| 02/25/2009 | CN101371877A Qi tian dropping pill extract and Qi tian dropping pill as well as method for producing the same |
| 02/25/2009 | CN101371876A Method for extracting and preparing total polysaccharide of compound abnormal savda mature agent |
| 02/25/2009 | CN101371875A Method for extracting and preparing total saponin of compound abnormal savda mature agent |
| 02/25/2009 | CN101371864A Medicament for treating varix and preparation method thereof |
| 02/25/2009 | CN101371849A Composition for curing coronary heart disease and preparation thereof |
| 02/25/2009 | CN101371834A Medicament composition containing amlodipine besylate and candesartan cilexetil and medicine box |
| 02/25/2009 | CN101371830A Medicament for inhibiting endothelial cell of cerebral vessels to secrete prostaglandin E2 |
| 02/25/2009 | CN101371829A Composition and preparation thereof for curing ischemic heart disease |
| 02/25/2009 | CN100463683C Shuxiening injection preparation and processing thereof |
| 02/24/2009 | US7495127 Calcium-activated potassium channel (BK channel) with opening activity equivalent to or higher than that of maxikdiol, and has high specificity; pimaric acid, dihydropimaric acid, dihydroisopimarinol, sandaracopimaric acid, isopimaric acid, and dihydroisopimaric acid |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7495086 TWEAK receptor |
| 02/24/2009 | US7495020 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 02/24/2009 | US7495018 An enzyme inhibitor of p38 MAP kinase, an antagonist of tumor necrosis factors or adenosine receptor, a thiazole with the 5-pyridyl group derivatives |
| 02/24/2009 | US7495004 Purine derivatives as liver X receptor agonists |
| 02/24/2009 | US7494991 For microbial infections specially Gram-positive bacterial infection; atherosclerosis-associated disease |
| 02/24/2009 | US7494990 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors |
| 02/24/2009 | US7494989 Pyridine compounds useful as N-type calcium channel antagonists |
| 02/24/2009 | US7494977 Polypeptides homologous to VEGF and BMP1 |
| 02/24/2009 | US7494976 Antiinflammatory agents; anticancer agents; cholesterol binding protein |
| 02/24/2009 | US7494973 Therapeutic fibrin-derived peptides and uses thereof |
| 02/24/2009 | US7494972 Administering a polypeptide comprising a V-type immunoglobulin domain followed by two C-type domains of soluble human receptor for advanced glycation endproduct (sRAGE) by injection, liposome, mouth, eye, nose or topically |
| 02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 02/24/2009 | US7494654 Compositions and methods for treating cardiovascular conditions with botulinum toxin |
| 02/24/2009 | US7494644 contacting a myocardial cells with genetic engineered mammalian cells modified to express a connexin 43 proteins, to establishing electrical coupling between cardiomyocytes and recombinant cells; treatment of cardiac disease or tissue repair |
| 02/24/2009 | CA2440333C Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
| 02/24/2009 | CA2432085C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |